You are here: Industry Insights > Ortho Clinical Diagnostics

News List

Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization prnasia
July 12, 2021
Ortho Clinical Diagnostics announced its VITROS® Anti-SARS-CoV-2 IgG Quantitative Test is the first quantitative COVID-19 IgG antibody test to receive U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response prnasia
May 24, 2021
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced the launch of the first quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.
Ortho Awarded Contract to Accelerate Antigen Test Development americanpharmaceuticalreview
September 27, 2020
Ortho Clinical Diagnostics announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and ...
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones prnasia
September 22, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and...
COVID-19 Antibody Test Released by Ortho Clinical Diagnostics prnasia
April 04, 2020
Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reage
Thermo Fisher collaborates with Ortho Clinical Diagnostics biospectrumasia
April 10, 2018
The agreement is part of Ortho's ongoing MicroTip Partnership Assays program.
FDA 510(k) Clears ORTHO CONNECT™ Middleware Solution from Ortho Clinical Diagnostics biospace
March 27, 2018
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that its ORTHO CONNECT V2.0 middleware solution received 510(k) clearance by FDA.